Is levofloxacin (Levaquin) used to treat chlamydia, a Sexually Transmitted Infection (STI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levofloxacin Treatment for Sexually Transmitted Infections

Levofloxacin is used to treat two specific STIs: gonorrhea (as an alternative regimen) and chlamydia (as an alternative regimen), but it is NOT a first-line treatment for either infection.

Gonorrhea Treatment

Levofloxacin 250 mg orally as a single dose was listed as an alternative regimen for uncomplicated urogenital and anorectal gonorrhea in the 2002 CDC guidelines 1. However, this recommendation is now outdated and should not be used in current practice due to widespread quinolone resistance.

Critical Limitations for Gonorrhea:

  • Quinolones (including levofloxacin) should NOT be used for gonorrhea in men who have sex with men, patients with recent foreign travel, or infections acquired in areas with high quinolone-resistant N. gonorrhoeae (QRNG) prevalence 1, 2
  • The CDC advises against using quinolones for gonorrhea treatment in most areas of the United States due to emergence of quinolone-resistant strains 2
  • Current first-line treatment for gonorrhea is ceftriaxone, not fluoroquinolones 1

Chlamydia Treatment

Levofloxacin 500 mg orally once daily for 7 days is an alternative regimen for chlamydia, not a first-line treatment 1, 3.

First-Line Chlamydia Treatment:

  • Azithromycin 1 g orally as a single dose OR doxycycline 100 mg orally twice daily for 7 days are the recommended first-line treatments, with 97-98% efficacy 1, 3

When to Use Levofloxacin for Chlamydia:

  • Levofloxacin is reserved for patients who cannot tolerate first-line medications 1, 3
  • The pharmacology and in vitro microbiologic activity of levofloxacin are similar to ofloxacin, allowing substitution at 500 mg once daily for 7 days 1
  • Clinical studies demonstrate 94.4% bacteriological efficacy for cervical chlamydial infections with levofloxacin 500 mg daily for 7 days 4

Important Contraindications:

  • Levofloxacin is contraindicated during pregnancy 3
  • For pregnant women with chlamydia, use azithromycin 1 g as a single dose or amoxicillin 500 mg three times daily for 7 days 3

Clinical Considerations

Advantages of Levofloxacin:

  • Broad spectrum activity against both Gram-positive and Gram-negative bacteria, including Chlamydia 5
  • Excellent oral bioavailability approaching 100% 5
  • Favorable pharmacokinetics with wide tissue distribution 1, 5

Disadvantages:

  • More expensive than doxycycline with no dosing advantage over first-line options 1
  • Requires 7-day course (no compliance advantage over doxycycline) 1
  • Less efficacious than azithromycin or doxycycline for chlamydia 1
  • Increasing concerns about antibiotic resistance with fluoroquinolone use 6

Common Pitfall to Avoid:

Do not use levofloxacin as first-line treatment for either gonorrhea or chlamydia. It should only be considered when patients cannot tolerate azithromycin, doxycycline, or erythromycin for chlamydia, and it should generally be avoided entirely for gonorrhea due to resistance patterns 1, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cefixime and Ofloxacin Combination Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The clinical pharmacokinetics of levofloxacin.

Clinical pharmacokinetics, 1997

Research

[Choice of antimicrobial drug for infections caused by Chlamydia trachomatis and Chlamydophila pneumoniae].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.